from pg 13 AR
"In June 2021, NEXTSTELLIS was launched into the US market and
is being supported by a highly experienced national women’s
health sales team. By August 2021, the sales team had held 20,000
in-person interactions with prescribers and reached more than
60% of priority prescriber targets."
Suggests there are about 33k priority prescribers in the US. The message is getting out - these docs have better things to do than talk about something of little interest. Assuming Mayne are not counting hang ups and line clicks - lol!
Ann: Annual Report to shareholders, page-2
Add MYX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.38 |
Change
0.440(11.2%) |
Mkt cap ! $372.6M | |||
| Open | High | Low | Value | Volume |
| $4.40 | $4.79 | $4.18 | $2.649M | 590.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1271 | $4.35 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.44 | 1271 | 1 |
View Market Depth
| Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
| MYX (ASX) Chart |